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OBJECTIVE: To evaluate the effectiveness of the Brazilian Cardioprotective Diet Program in reducing blood
pressures, fasting glucose levels and body mass indices in patients with established atherothrombotic disease.
METHOD: This randomized controlled pilot trial included outpatients who were over 45 years of age with
atherothrombotic cardiovascular disease. Group A, who received the Brazilian Cardioprotective Diet Program, had
weekly sessions with dietitians. Groups B and C received the usual dietary therapy that is given to patients with
cardiovascular diseases as proposed by the Brazilian guidelines. This diet had the same nutrient profile as that given
to Group A, but it was customized by the integration of typical Mediterranean foods. The difference between
Groups B and C was the number of sessions with the dietitian. Group B received weekly sessions, while group C only
had monthly sessions. ClinicalTrials.gov: NCT 01453166.
RESULTS: There was a greater reduction in systolic (7.8%) and diastolic (10.8%) blood pressures in Group A
compared with Group B (2.3% and 7.3%), and Group C (3.9% and 4.9%, respectively). Fasting glucose decreased by
5.3% and 2% in Groups A and B, respectively. Fasting glucose increased by 3.7% in Group C. The BMIs decreased by
3.5% and 3.3% in Groups A and B, respectively. Group C did not present with any changes in BMI. However, none of
these data showed statistical differences between the groups, which is methodologically acceptable in pilot trials.
CONCLUSIONS: The Brazilian Cardioprotective Diet Program seems to be more effective in reducing blood pressures,
fasting glucose levels, weights and BMIs in patients with previous cardiovascular disease compared with the diet
that has been proposed by the Brazilian guidelines.
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INTRODUCTION
Cardiovascular diseases (CVD) represent the leading
causes of mortality and morbidity in developed countries
worldwide, including Brazil (1). The control of cardiovas-
cular risk factors plays an important role in patients’ quality
of life and survival rates. The World Health Organization
has stated that over three-quarters of all CVD deaths may be
avoided with adequate changes in lifestyle, including diet
and exercise (2-3).
It is a consensus that the Mediterranean diet is effective
and possibly the most appropriate dietary intervention for
the prevention and treatment of CVD (2,3,4,5,6). This diet is
characterized by a low saturated fat intake in addition to a
high consumption of vegetables, fish, and olive oil and a
moderate consumption of wine (5). Nevertheless, adherence
to this diet seems to be an obstacle in successfully
controlling cardiovascular risk factors. Thus, cultural
adaptation seems to be the most appropriate means for its
management in countries outside of the Mediterranean
region (6). In Brazil, the Mediterranean diet differs vastly
from local customs, and this factor is seemingly related to
low adherence to the diet (7).
Brazil is a developing country with a wide range of
cultures and important socio-economic limitations. Addi-
tionally, significantly increased mortality and morbidity from
CVD have been observed, which compromises the govern-
ment’s finances. Brazil also possesses a rich variety of natural
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and nutritional resources that are potentially beneficial in the
treatment of CVD (8,9). Nevertheless, no studies have
explored the putative benefits of food resources that are part
of the Brazilian culture in comparison with the standard diet
that has been proposed by the Brazilian guidelines in the
prevention and treatment of cardiovascular diseases.
The aim of this randomized pilot trial was to evaluate the
Brazilian Cardioprotective Diet Program (a Brazilian ver-
sion of an accessible dietary therapy for cardiovascular
diseases) in reducing blood pressures, fasting glucose levels,
and body mass indices (BMIs) in patients with established
atherothrombotic disease.
METHODS
Trial design
We conducted a randomized (concealed) controlled pilot
trial to evaluate the effects of the Brazilian Cardioprotective
Diet Program on blood pressures, BMIs, and fasting glucose
levels in patients with established atherothrombotic disease.
The trial was designed by the Steering Committee and
registered at Clinicaltrials.gov (NCT01453166). The study
protocol was approved by the ethics committee of our
institution. All patients provided informed consent prior to
participation.
Study population
We included outpatients who were over 45 years of age
with established or previous atherothrombotic CVD occur-
ring in the past 10 years and who were at high CVD risk.
Atherothrombotic CVD was defined as follows: coronary
heart disease (stable or unstable angina pectoris, a history of
myocardial infarction or acute coronary syndrome, a prior
coronary revascularization procedure, a history of abdom-
inal segmental wall motion as shown by cardiac echocar-
diography or a fixed segmental defect in the radionuclide
imaging test), ischemic cerebrovascular disease (ischemic
stroke or transient ischemic attack), or peripheral vascular
disease (prior peripheral revascularization procedure or
amputation due to vascular disease).
The patients also had at least one of the following risk
factors: diabetes mellitus (serum glucose $100 mg/dl),
hypertension (systolic blood pressure $130 mm Hg or
diastolic blood pressure $85 mm Hg), smoking, dyslipide-
mia (low density lipoprotein (LDL) $160 mg/dL, triglycer-
ides $150 mg/dL, or total cholesterol (CT) $200 mg/dL),
family coronary artery disease history, asymptomatic
carotid disease or BMI .25 kg/m2 for adults and .28 kg/
m2 for seniors.
We excluded patients with neurocognitive or psychiatric
conditions (as defined by the clinical trial investigators),
pregnant or lactating women, patients with hepatic impair-
ment or renal insufficiency, and patients with a life
expectancy of less than six months (e.g., those with
metastatic malignancies).
Randomization and Allocation Concealment
After providing written informed consent, the patients
were randomized in a 1:1:1 ratio to receive one of three
dietary interventions (A, B, or C). The allocation conceal-
ment was guaranteed by using sealed and opaque envel-
opes that were numbered sequentially. The patients who
were allocated to Group A joined the Brazilian Cardio-
protective Diet Program, which involves a Brazilian version
of an accessible dietary therapy for cardiovascular diseases
and weekly counseling with dieticians. The patients in
Group B received the dietary therapy that was proposed by
the Brazilian guidelines for cardiovascular diseases and also
attended weekly counseling sessions with dietitians. Group
C received the same dietary intervention as Group B, but the
patients were counseled monthly.
Study interventions
The nutrient profiles of the diets were based on the
Brazilian guidelines for cardiovascular disease treatment
(10,11,12). The diets contained 50-60% of energy from
carbohydrates, 15% from proteins, and 25-35% from fats.
In addition, 20-30 g/d of fiber and 2,000 mg/d of sodium
were recommended. The concentrations of saturated,
monounsaturated, and polyunsaturated fatty acids were
,7%, ,20%, and ,10%, respectively. The total dietary
energy intake was adjusted only for patients with a baseline
BMI .25 kg/m2.
The main difference between the Brazilian Cardio-
protective Diet Program, which involves a Brazilian version
of an accessible dietary therapy for cardiovascular diseases,
and the usual dietary therapy that is prescribed for
cardiovascular diseases was the consideration of energy
density. The Brazilian Cardioprotective Diet Program
helped the patients to avoid high energy density foods
(.1 kcal/g), thus allowing them to eat more and consume
fewer calories. As they made the right food choices, they felt
less restricted, aiding in the improvement of adherence.
In general, the Brazilian Cardioprotective Diet Program
features nutritional recommendations that are feasible for
the Brazilian population. Accordingly, the diet composition
allows for the easy access and full use of foods, in addition
to the prioritization of regional foods that are culturally
accepted by the patients (rice, bean, soy oil, and Brazilian
fruits and vegetables).
Group A participated in the Brazilian Cardioprotective
Diet Program. This group attended weekly session with
dietitians. These were conducted in person, by phone or in a
gourmet shop. During attendance at the gourmet shop, the
patients received tips for eating in restaurants, instructions
on label reading and a list of typical Brazilian recipes that
were adjusted for nutrients and energy densities. This
nutritional prescription protocol was developed by dieti-
tians from our hospital.
Groups B and C received the usual dietary therapy that is
prescribed to patients with cardiovascular diseases as
proposed by the Brazilian guidelines. This diet had the
same nutrient profile as that which was presented in Group
A but was customized by the integration of typical
Mediterranean foods (e.g., olives, olive oil, chestnuts,
walnuts, almonds, hazelnuts, peanuts, and cold water fish).
The difference between groups B and C was the number of
sessions with the dietitian. Group B received weekly
sessions that were conducted in person or by telephone,
and Group C had monthly sessions that were conducted in
person.
Anthropometric measurements and 24-h dietary recalls
were performed by well-trained dietitians. The patients
described their average portion sizes for food items in terms
of household measurements, the standard weights of food
items and validated food portion photographs of known
weights. The Nutriquanti diet system (Sa˜o Paulo, SP, Brazil)
(13), which is an online computer program that is based on
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the Brazilian food database, was used to calculate the
Brazilian Cardioprotective Diet Program and dietary assess-
ments. Data quality control was guaranteed by weekly
meetings between the investigators and dieticians.
Study procedures
Anthropometric measurements and laboratory tests were
performed at baseline and after 6 and 12 weeks. At each
contact with the dietitian (weekly or monthly), the dietary
intake profile was assessed by a 24-hour dietary recall. The
first nutritional session lasted for 60 minutes. The follow-up
counseling sessions lasted for 30 minutes once the teaching
and nutrition goals were reviewed. The phone interviews
lasted approximately 15 minutes and included just the time
that was necessary to assess the 24-hour dietary recall.
Outcomes
The primary outcome of this pilot trial was the changes in
blood pressures that occurred after 12 weeks of adherence to
the Cardioprotective Diet Program. The secondary out-
comes of this pilot trial were improved BMIs and fasting
glucose levels. Considering that this was a pilot trial, we
chose one well-established biochemical, hemodynamic, and
anthropometric parameter as the endpoint.
Figure 1 - Flow diagram of the participants in the study.
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Biochemical analysis
The blood samples were collected and handled according
to hospital routines. Fasting glucose was determined by
an enzymatic colorimetric dry chemistry method (Ortho-
Clinical Diagnostics VITROS 5.1) at the Center for
Laboratory Medicine at the Hospital do Corac¸a˜o.
Blood pressures and weights
Blood pressures were assessed by an auscultatory method
following the recommendations of the American Heart
Association (14). The patients were seated comfortably with
their backs supported, and their upper arms were free of
constrictive clothing. Arms were supported at heart level,
and the mercury columns were deflated at 2–3 mm/sec. The
first and last audible sounds were recorded as the systolic
and diastolic pressures, respectively. Two readings were
performed at intervals of at least 1 minute, and the average
was taken as the patient’s blood pressure. If there was a
difference of greater than 5 mm Hg between the first and
second readings, additional (one or two) readings were
obtained, and the average of these multiple readings was
used (17).
To assess the weights, we used a digital scale with a
maximum capacity of 150 kg. The patients dressed in as
little clothing as possible and removed objects that could
interfere with measurements. Heights were measured using
a stadiometer with a bilateral scale from 35 to 213 cm and a
resolution of 0.1 cm. BMIs were calculated by dividing the
patients’ current weights by the square of their heights in
meters and classified according to WHO recommendations
(15).
Sample size
Considering this pilot trial, the sample size was set to
compare the groups in relation to changes in the systolic
and diastolic blood pressures following dietary interven-
tion. We anticipated a standard deviation of 14 mm Hg in
the systolic or diastolic blood pressures. To detect a
difference of 7 mm Hg in the systolic and diastolic blood
pressures with 80% statistical power and a two-tailed
p-value of 5%, we sought to include 50 patients in each of
the three groups.
Statistical analyses
All analyses followed the ‘‘intention to treat’’ principle.
To evaluate the effects of the diet interventions, we used an
analysis of variance (ANOVA). In cases of significant group
effects, we used multiple comparisons with Bonferroni
corrections to locate the differences. All tests were
performed with the SPSS statistical software or STATA SE
11 for Windows (College Station, USA). Statistical signifi-
cance was defined as p,0.05.
Quality Control
Due to the type of intervention in this pilot trial, it was not
possible to blind the investigators and participants. To
improve quality control, the laboratory technicians who
performed the biochemical tests were not aware of which
group the patients had been allocated to. Data quality
control was guaranteed by weekly contacts with investiga-
tors, and general feedback was provided at investigators’
meetings.
Moreover, two independent investigators evaluated the
database, and anthropometric measurements were per-
formed twice to ensure the reliability of the data.
RESULTS
Baseline Characteristics
This trial enrolled 117 patients from September to
December 2011 in a cardiology hospital (Figure 1). The
baseline characteristics, such as the medication intakes,
were similar between the groups (Table 1). More than 70%
of the patients presented with histories of hypertension
and/or dyslipidemia in addition to reporting the frequent
use of antihypertensive and hypolipidemic drugs. The
Table 1 - Baseline characteristics of participants.
Variables Group
A B C
(n=42) (n = 41) (n = 39)
Male sex, No. (%) 31 (73.8%) 26 (63.4%) 24 (61.5%)
Age, mean¡SD, y 62 (7) 65 (8) 62 (11)
Weight, mean¡SD, kg 80.6 (14.6) 88.4 (16.0) 84.3 (15.9)
High, mean¡SD, cm 167 (9) 169 (10) 168 (10)
BMI, mean¡SD, kg/m2 28.9 (3.9) 30.9 (4.5) 30.0 (4.7)
CAD, No. (%) 41 (100.0%) 40 (97.6%) 37 (97.4%)
Ischemic stroke/transient ischemic attack, No. (%) 1 (2.4%) 2 (4.9%) 1 (2.6%)
PAD, No. (%) 3 (7.3%) 1 (2.4%) 1 (2.6%)
Hypertension, No. (%) 35 (85.4%) 30 (73.2%) 32 (84.2%)
Diabetes mellitus, No. (%) 17 (41.5%) 15 (36.6%) 16 (42.1%)
Smoking, No. (%) 6 (14.6%) 5 (12.2%) 5 (13.2%)
Dyslipidemia, No. (%) 37 (90.2%) 34 (82.9%) 33 (86.8%)
CAD family history, No. (%) 32 (78.0%) 28 (68.3%) 27 (71.1%)
Asymptomatic carotid disease, No. (%) 2 (4.9%) 5 (12.2%) 6 (15.8%)
Overweight, No. (%) 27 (64.3%) 30 (75.0%) 30 (78.9%)
Hypoglycemic drugs, No. (%) 16 (39.0%) 15 (36.6%) 16 (42.1%)
Antihypertensive drugs, No. (%) 39 (95.1%) 37 (92.5%) 37 (97.4%)
Hypolipidemic drugs, No. (%) 35 (85.4%) 35 (87.5%) 36 (94.7%)
CAD: coronary artery disease; PAD: peripheral arterial disease.
A Brazilian Cardioprotective Diet Trial
Weber B et al.
CLINICS 2012;67(12):1407-1414
1410
T
a
b
le
2
-
In
d
iv
id
u
a
l
d
a
il
y
ca
lo
ri
c
in
ta
k
e
a
t
b
a
se
li
n
e
a
n
d
th
re
e
m
o
n
th
s.
G
ro
u
p
A
G
ro
u
p
B
G
ro
u
p
C
p
-v
a
lu
e
B
a
se
li
n
e
p
-v
a
lu
e
b
e
tw
e
e
n
d
ie
ts
B
a
se
li
n
e
3
M
o
n
th
s
B
a
se
li
n
e
3
M
o
n
th
s
B
a
se
li
n
e
3
M
o
n
th
s
T
im
e
G
ro
u
p
T
im
e
x
G
ro
u
p
T
o
ta
l
C
a
lo
ri
c
In
ta
k
e
1
,5
7
4
.1
2
¡
5
2
3
.4
3
1
,3
7
0
.0
8
¡
3
2
7
.6
7
1
,6
0
7
.0
5
¡
4
8
1
.3
3
1
,4
2
0
.5
9
¡
2
7
3
.1
1
1
,8
6
7
.9
9
¡
7
6
7
.9
4
1
,4
1
7
.3
0
¡
3
8
6
.9
9
0
.6
9
,
0
.0
1
0
.1
7
0
.0
5
P
ro
te
in
(g
/d
)
7
1
.4
0
¡
3
1
.8
2
6
5
.2
9
¡
1
6
.3
3
8
1
.1
3
¡
2
5
.7
8
7
7
.3
3
¡
1
7
.1
8
8
6
.2
6
¡
3
7
.1
3
6
8
.6
0
¡
2
2
.7
1
0
.1
1
,
0
.0
1
0
.0
5
0
.1
3
P
ro
te
in
(%
to
ta
l
ca
lo
ri
e
in
ta
k
e
)
1
8
.1
1
9
.0
2
0
.2
2
1
.7
1
8
.4
1
9
.3
-
C
a
rb
o
h
yd
ra
te
(g
/d
)
1
9
1
.9
9
¡
6
3
.0
1
1
7
1
.7
0
¡
4
1
.3
2
1
9
1
.1
2
¡
6
7
.5
1
1
5
7
.5
5
¡
3
2
.6
1
2
1
8
.6
0
¡
1
0
8
.8
2
1
6
8
.1
6
¡
5
7
.9
0
0
.2
5
,
0
.0
1
0
.3
4
0
.1
5
C
a
rb
o
h
yd
ra
te
(%
to
ta
l
ca
lo
ri
e
in
ta
k
e
)
4
8
.7
5
0
.1
4
7
.5
4
4
.4
4
6
.8
4
7
.4
-
T
o
ta
l
fa
t
(g
/d
)
5
6
.4
6
¡
2
2
.1
4
4
8
.9
9
¡
1
4
.3
5
5
8
.8
8
¡
2
3
.8
1
5
3
.8
8
¡
1
5
.2
0
7
2
.8
2
¡
3
8
.1
8
5
3
.2
0
¡
1
7
.5
3
0
.3
2
,
0
.0
1
0
.0
5
0
.0
5
T
o
ta
l
fa
t
(%
to
ta
l
ca
lo
ri
e
in
ta
k
e
)
3
2
.2
3
2
.1
3
2
.9
3
4
.1
3
5
.0
3
3
.8
-
Sa
tu
ra
te
d
Fa
t
(g
/d
)
1
8
.0
5
¡
8
.2
9
1
4
.7
8
¡
5
.1
0
2
0
.1
8
¡
9
.4
5
1
7
.4
8
¡
4
.9
2
2
3
.4
1
¡
1
3
.8
8
1
5
.3
3
¡
5
.9
8
0
.9
2
,
0
.0
1
0
.1
1
0
.0
6
Sa
tu
ra
te
d
Fa
t
(%
to
ta
l
ca
lo
ri
e
s
in
ta
k
e
)
1
0
.3
9
.7
1
1
.3
1
1
.0
1
1
.3
9
.7
-
M
o
n
o
u
n
sa
tu
ra
te
d
Fa
tt
y
A
ci
d
s
(g
/d
)
1
6
.6
8
¡
7
.8
9
1
3
.9
0
¡
4
.1
3
1
6
.7
4
¡
7
.2
2
1
5
.8
9
¡
4
.8
2
1
9
.2
7
¡
7
.7
7
1
5
.0
3
¡
5
.9
3
0
.2
4
,
0
.0
1
0
.2
8
0
.1
8
M
o
n
o
u
n
sa
tu
ra
te
d
Fa
tt
y
A
ci
d
s
(%
to
ta
l
ca
lo
ri
e
s
in
ta
k
e
)
9
.5
9
.1
9
.3
1
0
.0
9
.2
9
.7
-
P
o
ly
u
n
sa
tu
ra
te
d
Fa
t
(g
/d
)
1
6
.1
8
¡
6
.0
9
1
4
.9
4
¡
5
.2
2
1
4
.6
4
¡
5
.8
7
1
4
.0
9
¡
4
.6
1
1
8
.3
3
¡
9
.6
7
1
5
.4
7
¡
6
.6
8
0
.1
0
.0
3
0
.1
3
0
.3
9
P
o
ly
u
n
sa
tu
ra
te
d
Fa
t
(%
to
ta
l
ca
lo
ri
e
s
in
ta
k
e
)
9
.2
9
.8
8
.2
8
.9
8
.8
9
.8
-
C
h
o
le
st
e
ro
l
(m
g
/d
)
2
2
4
.0
8
¡
1
5
9
.5
6
1
7
8
.0
0
¡
6
3
.2
6
2
3
0
.0
2
¡
9
1
.7
5
2
3
2
.9
9
¡
7
2
.1
2
2
5
3
.0
4
¡
1
4
8
.6
7
1
8
8
.2
6
¡
8
9
.6
8
0
.6
2
,
0
.0
1
0
.4
0
.0
7
D
ie
ta
ry
fi
b
e
r
(g
/d
)
2
0
.5
3
¡
9
.5
2
1
8
.8
0
¡
5
.9
5
1
7
.0
6
¡
7
.3
5
1
6
.4
6
¡
4
.4
9
2
3
.4
3
¡
1
3
.7
2
1
9
.3
7
¡
8
.8
4
0
.0
3
*
0
.0
2
0
.0
3
0
.2
6
So
d
iu
m
(m
g
/d
)
2
8
0
3
.4
4
¡
1
0
4
8
.1
4
2
4
3
2
.8
2
¡
6
7
4
.8
2
2
6
4
1
.3
¡
9
1
0
.4
9
2
4
7
3
.5
8
¡
5
7
1
.8
7
3
3
8
4
.7
8
¡
1
8
6
0
.6
0
2
6
6
6
.0
5
¡
8
5
8
.6
1
0
.0
5
*
,
0
.0
1
0
.0
5
0
.1
4
*
D
if
fe
re
n
ce
s
b
e
tw
e
e
n
g
ro
u
p
s
B
a
n
d
C
u
si
n
g
o
n
e
-w
a
y
A
N
O
V
A
(p
,
0
.0
5
).
CLINICS 2012;67(12):1407-1414 A Brazilian Cardioprotective Diet Trial
Weber B et al.
1411
baseline characteristics were well balanced between the
groups, except in the case of asymptomatic carotid disease.
Participation in all visits, phone calls and contact with the
dietitians was evaluated in Groups A and B due to the
similarities in the number of contacts (weekly sessions,
which in Group C were monthly sessions). The attendance
of patients in Group A at the meetings with the dieticians
was higher than that in Group B (88.1% versus 78%,
respectively).
The analyses of the dietary recalls that were collected
during the intervention period show that the caloric intakes
decreased between the initial and final assessments in a
similar manner in all three groups. The consumption of
total cholesterol, saturated fatty acids, and sodium also
decreased (Table 2). The ingestion of all nutrients showed
lower variabilities following the intervention period, indi-
cating greater homogeneity in consumption.
Effects on risk factors
Considering our primary outcome, there was a greater
reduction in the systolic (7.8%) and diastolic (10.8%) blood
pressures in Group A compared with Groups B (2.3% and
7.3%) and C (3.9% and 4.9%, respectively). Considering our
secondary outcome, the fasting glucose levels decreased by
5.3% and 2% in Groups A and B, respectively. In Group C,
they increased by 3.7%. The BMIs decreased by 3.5% and
3.3% in Groups A and B, respectively. The BMIs in Group C
did not change (Figure 2). Nevertheless, none of these data
showed statistical differences between the groups, which is
methodologically acceptable in pilot trials (Table 3).
DISCUSSION
This is the first study to investigate the clinical effects of a
diet that is based on widely available foods in the Brazilian
culture on cardiovascular risk factors. The main finding of
this randomized pilot trial was that Group A, who received
the Brazilian Cardioprotective Diet Program, showed
greater decreases in blood pressures, serum glucose levels,
and BMIs compared with Groups B and C, who received the
dietary therapy that has been proposed by the Brazilian
guidelines for CVD.
Among the various dietary interventions, there is a consensus
that the Mediterranean diet is effective and possibly more
appropriate for the prevention and treatment of CVD (2,7). This
diet is characterized by the low intake of saturated fat, high
consumption of vegetables, fish, olive oil, and moderate
consumption of wine (8). Despite the remarkable effects of the
Mediterranean diet, there is some controversy regarding its
administration in countries outside of the Mediterranean region.
The Lyon Diet Heart Study showed no differences
between patients that followed the Mediterranean diet and
those that followed common eating habits in the secondary
prevention of CAD. This study investigated the total
cholesterol levels (650 vs. 617 mmol/l; p.0.05), LDLs (452
vs. 418 mmol/l; p.0.05), HDLs (116 vs. 128 mmol/l;
p.0.05), triglycerides (215 vs. 185 mmol/l; p.0.05), weights
(74.2 vs. 75.6 kg; p.0.05), and systolic (119 vs. 126 mm Hg;
p.0.05) and diastolic (74 vs. 78 mm Hg; p.0.05) blood
pressures of patients during a period of three years of
follow-up (16). Our pilot study, which was conducted
Figure 2 - Mean and standard deviation of outcomes in Groups A, B, and C.
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during a brief 12-week period, showed a trend of decreasing
blood pressures, BMIs, and fasting plasma glucose levels;
these factors were not evaluated in the Lyon study.
Moreover, the only Brazilian study that evaluated the
influence of the Mediterranean diet in secondary prevention
showed no differences in BMIs, systolic or diastolic blood
pressures, or fasting glucose levels (10).
However, studies that have adapted the Mediterranean
diet to the tastes and cultural habits of the local population
observed greater effectiveness in reducing cardiovascular
risk factors. An Indian study showed that after one year of
dietary intervention, blood glucose levels decreased by
1.36 mmol/l, systolic blood pressures decreased by
13.4 mm Hg, and diastolic blood pressures decreased by
9.3 mm Hg (17). A Swedish study (NORDIET) that also
adapted the Mediterranean dietary habits for patients in the
primary prevention program observed reductions in sys-
tolic blood pressures by 9.5 mm Hg and weights by 14.4 kg
(18).
In our pilot study, the Brazilian Cardioprotective Diet
Program seemed to be more efficient than the diet
intervention that was proposed by the Brazilian guidelines.
We believe that a cardioprotective diet including foods that
are widely available in Brazil played a key role in our
results. Our findings are of potentially great importance to
public health in our country, considering the promising
cost/benefit relationship (19,20,21). The financial costs of
the foods were not assessed in this pilot study; however, the
diet that was proposed by the Brazilian guidelines to control
cardiovascular risk factors, which involves components of
the Mediterranean diet, is costly for a major proportion of
the Brazilian population. Thus, we propose a new interven-
tion with potentially low costs and high feasibility in Brazil.
The efficacy of the Brazilian Cardioprotective Diet Program
is substantiated by the fact that the diet that has been
proposed by the Brazilian guidelines is not widely available
nor is it in accordance with the Brazilian culture.
Despite our encouraging results, we cannot generalize
and recommend the implementation of a cardioprotective
diet following the same format as in this pilot study in all
Brazilian regions. Our country has continental dimensions
and presents with multicultural characteristics that should
be considered when interpreting our data and prescribing
diets. For the improvement of cardioprotective diets and to
contemplate the cultural diversities of the various regions of
our country, a multicenter trial is needed. However, the
foundation for the Brazilian Cardioprotective Diet has been
established.
Study limitations
This study had some limitations; we did not assess the
patients’ dietary adherences, we only assessed their
adherences to the intervention programs. Nevertheless, we
observed that the numbers of absences were higher in
Group B than in Group A, which was the group following
the Brazilian Cardioprotective Diet Program. Our randomi-
zation process did not include a web-based automated
randomization system, which could represent a methodo-
logical disadvantage. Moreover, this study did not find
statistically significant differences between groups, which is
acceptable in pilot trials. We believe that the statistical
significance will be evident when the Brazilian
Cardioprotective Diet Program is assessed in a larger
population over all regions of Brazil.T
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The Brazilian Cardioprotective Diet Program seems to be
more effective in reducing blood pressures, fasting glucose
levels, weights, and BMIs in patients with previous
cardiovascular diseases compared with the diet that was
proposed by the Brazilian guidelines. The Brazilian
Cardioprotective Diet Program can be considered as an
alternative for Brazilian patients with cardiovascular risk
factors; however, it will be necessary to test this intervention
on a larger scale.
ACKNOWLEDGMENTS
The Brazilian Cardioprotective Diet Trial is funded by the Brazilian
Ministry of Health (Programa Hospitais de Excelencia a Servic¸o do SUS).
The sponsor had no role in the analyses, study design or decision to publish
these results.
AUTHOR CONTRIBUTIONS
Weber B, Galante AP and Berwanger O conceived, designed and
coordinated the study, and helped to draft the manuscript. Carvalho VO,
Bersch-Ferreira AC, Buehler AM, Torreglosa CR, Espı´rito-Santo JA, Ross-
Fernandes M, Soares RM, Lara ES and Costa RP participated in the study
design and helped to draft the manuscript. Victor ES performed the
statistical analysis. All the authors read and approved the final version of the
manuscript.
REFERENCE
1. World Health Organization. Mortality estimates by cause, age, and sex
for the year 2008. 2011. Geneva: WHO.
2. Hooper L, Griffiths E, Abrahams B, Alexander W, Atkins S, Atkinson G,
et al. Dietetic guidelines: diet in secondary prevention of cardiovascular
disease (first update, June 2003). J Hum Nutr Diet. 2004;17(4):337-49,
http://dx.doi.org/10.1111/j.1365-277X.2004.00533.x.
3. Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller ER, III, et al.
Effects of protein, monounsaturated fat, and carbohydrate intake on
blood pressure and serum lipids: results of the Omni Heart randomized
trial. JAMA. 2005;294(19):2455-64, http://dx.doi.org/10.1001/jama.294.
19.2455.
4. Parikh P, McDaniel MC, Ashen MD, Miller JI, Sorrentino M, Chan V,
et al. Diets and cardiovascular disease: an evidence-based assessment.
J Am Coll Cardiol. 2005;45:1379-87, http://dx.doi.org/10.1016/j.jacc.
2004.11.068.
5. Willett WC, Sacks F, Trichopoulou A, Drescher G, Ferro-Luzzi A, Helsing
E, et al. Mediterranean diet pyramid: a cultural model for healthy eating.
Am J Clin Nutr. 1995;61(6 Suppl):1402S-6S.
6. Bellisle F. Infrequently asked questions about the Mediterranean diet.
Public Health Nutr. 2009;12(9A):1644-7, http://dx.doi.org/10.1017/
S1368980009990498.
7. Thomazella MC, Go´es MF, Andrade CR, Debbas V, Barbeiro DF, Correia
RL, et al. Effects of high adherence to mediterranean or low-fat diets in
medicated secondary prevention patients. Am J Cardiol. 2011;108
(11):1523-9, http://dx.doi.org/10.1016/j.amjcard.2011.07.008.
8. Maranha˜o PA, Kraemer-Aguiar LG, de Oliveira CL, Kuschnir MC, Vieira
YR, Souza MG, et al. Brazil nuts intake improves lipid profile, oxidative
stress and microvascular function in obese adolescents: a randomized
controlled trial. Nutr Metab (Lond). 2011;8(1):32, http://dx.doi.org/10.
1186/1743-7075-8-32.
9. Guerra JF, Magalha˜es CL, Costa DC, Silva ME, Pedrosa ML. Dietary ac¸ai
modulates ROS production by neutrophils and gene expression of liver
antioxidant enzymes in rats. J Clin Biochem Nutr. 2011;49(3):188-94,
http://dx.doi.org/10.3164/jcbn.11-02.
10. Sposito AC, Caramelli B, Fonseca FAH, Bertolami MC. IV Diretriz Brasileira
sobre Dislipidemias e Prevenc¸a˜o da Aterosclerose: Departamento de
Aterosclerose da Sociedade Brasileira de Cardiologia. Arq. Bras. Cardiol.
2007;88:suppl1, http://dx.doi.org/10.1590/S0066-782X2007000700002.
11. Sociedade Brasileira de Cardiologia; Sociedade Brasileira de
Hipertensa˜o; Sociedade Brasileira de Nefrologia. VI Diretrizes
Brasileiras de Hipertensa˜o. Arq Bras Cardiol. 2010;95(supl.1): 1-51.
12. Sociedade Brasileira de Cardiologia. I Diretriz Brasileira de Diagno´stico e
Tratamento da Sı´ndrome Metabo´lica. Arq Bras Cardiol. 2005;84(supl.
1):1-28.
13. Galante AP. Desenvolvimento e validac¸a˜o de um me´todo computador-
izado para avaliac¸a˜o do consumo alimentar, preenchido por indivı´duos
adultos utilizando a Web. Tese de doutorado. Universidade de Sa˜o
Paulo;2007.
14. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves JW, Hill MN, et al.
Recommendations for blood pressure measurement in humans: an AHA
scientific statement from the Council on High Blood Pressure Research
Professional and Public Education Subcommittee. J Clin Hypertens
(Greenwich). 2005;7(2):102-9, http://dx.doi.org/10.1111/j.1524-6175.
2005.04377.x.
15. BMI classification - WHO http://apps.who.int/bmi/index.jsp?intro
Page=intro_3.html.
16. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N.
Mediterranean diet, traditional risk factors, and the rate of cardiovas-
cular complications after myocardial infarction: final report of the Lyon
Diet Heart Study. Circulation. 1999;99:779-85, http://dx.doi.org/10.
1161/01.CIR.99.6.779.
17. Singh RB, Rastogi SS, Verma R, Laxmi B, Singh R, Ghosh S, et al.
Randomised controlled trial of cardioprotective diet in patients with
recent acute myocardial infarction: results of one year follow up. BMJ.
1992;304(6833):1015-9, http://dx.doi.org/10.1136/bmj.304.6833.1015.
18. Adamsson V, Reumark A, Fredriksson IB, Hammarstro¨m E, Vessby B,
Johansson G, et al. Effects of a healthy Nordic diet on cardiovascular risk
factors in hypercholesterolaemic subjects: a randomized controlled trial
(NORDIET). J Intern Med. 2011;269:150-9, http://dx.doi.org/10.1111/j.
1365-2796.2010.02290.x.
19. Solimene MC. Coronary heart disease in women: a challenge for the 21st
century. Clinics. 2010;65:99-106, http://dx.doi.org/10.1590/S1807-
59322010000100015.
20. Torres MR, Ferreira Tda S, Nogueira Lde P, do Nascimento DC,
Sanjuliani AF. Dietary counseling on long-term weight loss in over-
weight hypertensive patients. Clinics. 2011;66(10):1779-85.
21. Azevedo CH, Wajngarten M, Prete AC, Diament J, Maranha˜o RC.
Simultaneous transfer of cholesterol, triglycerides, and phospholipids to
high-density lipoprotein in aging subjects with or without coronary
artery disease. Clinics. 2011;66(9):1543-8.
A Brazilian Cardioprotective Diet Trial
Weber B et al.
CLINICS 2012;67(12):1407-1414
1414
